Department of Medicine, Royal Hampshire County Hospital, Romsey Road, Winchester, SO22 5DG, UK.
Diabetologia. 2013 Jul;56(7):1462-70. doi: 10.1007/s00125-013-2904-2. Epub 2013 Apr 24.
In this review, we explore the concept of 'double diabetes', a combination of type 1 diabetes with features of insulin resistance and type 2 diabetes. After considering whether double diabetes is a useful concept, we discuss potential mechanisms of increased insulin resistance in type 1 diabetes before examining the extent to which double diabetes might increase the risk of cardiovascular disease (CVD). We then go on to consider the proposal that weight gain from intensive insulin regimens may be associated with increased CV risk factors in some patients with type 1 diabetes, and explore the complex relationships between weight gain, insulin resistance, glycaemic control and CV outcome. Important comparisons and contrasts between type 1 diabetes and type 2 diabetes are highlighted in terms of hepatic fat, fat partitioning and lipid profile, and how these may differ between type 1 diabetic patients with and without double diabetes. In so doing, we hope this work will stimulate much-needed research in this area and an improvement in clinical practice.
在这篇综述中,我们探讨了“双重糖尿病”的概念,即 1 型糖尿病伴有胰岛素抵抗和 2 型糖尿病特征的一种病症。在考虑双重糖尿病是否是一个有用的概念之后,我们讨论了 1 型糖尿病中胰岛素抵抗增加的潜在机制,然后研究了双重糖尿病是否会增加心血管疾病(CVD)的风险。接着,我们探讨了一个观点,即强化胰岛素治疗方案引起的体重增加可能与某些 1 型糖尿病患者的心血管风险因素增加有关,并探讨了体重增加、胰岛素抵抗、血糖控制和心血管结局之间的复杂关系。我们还根据肝脂肪、脂肪分布和血脂谱,强调了 1 型糖尿病与 2 型糖尿病之间的重要比较和对比,以及这些差异在伴有和不伴有双重糖尿病的 1 型糖尿病患者之间是如何不同的。通过这样做,我们希望这项工作能够激发该领域急需的研究,并改善临床实践。